AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...
Add galleries to your saved list and come back to them any time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback